-- 
Merck, J&J’s Simponi Drug Gets U.K. Backing for Spinal Arthritis

-- B y   K r i s t e n   H a l l a m
-- 
2011-06-23T23:01:00Z

-- http://www.bloomberg.com/news/2011-06-23/merck-j-j-s-simponi-drug-gets-u-k-backing-for-spinal-arthritis.html
Merck & Co. and  Johnson & Johnson (JNJ) ’s
Simponi won backing from the U.K. National Institute for Health
and Clinical Excellence as a treatment option in draft guidance
on a progressive form of spinal arthritis known as ankylosing
spondylitis. The agency, known as NICE, commented in an e-mailed
statement.  To contact the reporter on this story:
Kristen Hallam in London at 
 khallam@bloomberg.net   To contact the editor responsible for this story:
Phil Serafino at   pserafino@bloomberg.net  